2001;15(11):871-904. doi: 10.2165/00023210-200115110-00005.Rendell JM, Gijsman HJ, Keck P, Goodwin GM, Geddes JR.Cochrane Database Syst Rev.
2014 Jul;231(14):2811-8. doi: 10.1007/s00213-014-3453-1. 0000000776 00000 n vue d’ensemble. 3$�ǝ�X
A substantial number of patients with mania have significant concomitant depressive features, and they may respond differently to mood stabilizers than patients with pure mania.
Among those manic subjects without prominent depressive symptoms (olanzapine, n = 91; placebo, n = 87), mean Y-MRS improvement from baseline to endpoint with olanzapine (-11.5 points) versus placebo (-6.13 points) was comparable to the improvement seen with olanzapine versus placebo in the dysphoric mania subgroup ( = 0.476, test of interaction).
dysphoric mania is a common disorder and the outcomes are generally poorer than pure manic and depressive episodes, little is known about how to treat such a condition and new evidence based strategies are needed. 2003 Feb;5(1):1-5. doi: 10.1034/j.1399-5618.2003.02237.x.Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A.Arch Gen Psychiatry. La manie dysphorique est le terme utilisé dans le passé pour ce que nous appelons maintenant un épisode avec caractéristiques mixtes, bien que certains professionnels de la santé utilisent encore ce terme. Dysphoric mania episodes can be very dangerous for patients, because the risk of substance abuse and suicide attempts tends to increase during this mixed bipolar state. 0000001591 00000 n doi: 10.1097/00004714-200304000-00005. Nevertheless, a variable prevalence of dysphoric mania has been reported. H��W�r��}�W�#��0w�/�%����L�S��C`D�, M��V��9=@�ś�*�-$g�z�t��7s���ɫ���b2�w��9�3��6���n��z��8���"�?�����u���V��R�L�LϦ�qln��vY�&����X�RY6R��j�ر�0u锜:���JE�>��ҒM���˙r7��j�%�u#K��x��t|����4��W0L��D�*-$��*��F�k�6l[vZ�Z���XY�i�^K|�ۉ�*X�m���L�kg��p��%�j�R%n�HhUߓ��a�,p!��,U�ew���o�� ���f��J�U�J5R4Rθ���E��e�#���j�S�+��t;���Z2Ꚍ�.s|nI��~��7���1�ݲ/�;,�/�)6�;���Q�֓ � -�c1������]���� ���:x �'S}7�"y l�����>�����͛��٧���ŧ˷����x�a�ۜ��t�uQU9��Zۢc;jê;��M^Q֢T�Eq Please enable it to take advantage of the complete set of features! Wolters Kluwer Certains professionnels de la santé mentale qui traitent les personnes qui utilisent la psychanalyse peuvent encore se référer à la condition par ce terme.
0000018655 00000 n Methods: Eighty-six patients who met DSM-IV criteria for mania were evaluated at admission with a protocol that included … 0000001259 00000 n The depression aspect of dysphoric mania can bring extended periods of worrying.
0000001197 00000 n
0000000016 00000 n Today, this is described as a mixed feature of bipolar disorder. Manic episodes can include mania … 2015 Sep;29(9):725-40. doi: 10.1007/s40263-015-0275-6.Psychopharmacology (Berl). trailer Mean changes in Young-Mania Rating Scale (Y-MRS) and HAM-D scores during 3 weeks of treatment were examined. The aim of this study was to estimate the prevalence of dysphoric mania among hospitalized patients and to assess the effectiveness of olanzapine in this type of patients. In acutely ill …
0000003145 00000 n This post-hoc analysis explored the response characteristics of olanzapine versus placebo in bipolar I manic patients with dysphoric and nondysphoric mania (differentiated by baseline Hamilton Depression Rating Scale [HAM-D] score of >20). 0000017502 00000 n
0000003596 00000 n 0000003399 00000 n Two similar, double-blind, randomized trials comparing olanzapine, 5-20 mg, to placebo were pooled for these analyses (N = 246). Twenty-eight percent of patients had dysphoric mania (olanzapine, n = 33; placebo, n = 35). (�*{��`��^m��&k Unable to load your delegates due to an error
2003;2003(3):CD004040.
COVID-19 is an emerging, rapidly evolving situation. 0 0000016716 00000 n Unable to load your collection due to an error 0000020889 00000 n Wolters Kluwer 0000021601 00000 n In acutely ill manic patients with significant depressive symptoms, olanzapine demonstrated a broad spectrum of efficacy, effectively treating both manic and depressive symptoms. ��oҸ$��p��r�-K�F����sR[��E��i��BL�w钨R��Q)Q�b�� 2012 Jun;262 Suppl 1:1-48. doi: 10.1007/s00406-012-0323-x.
Dysphorique Mania: symptômes, traitement, et plus. Dysphoric mania, or mixed mania, is something I wouldn’t wish on my worst enemy.
2001 Apr;62(4):273-81. doi: 10.4088/jcp.v62n0410.CNS Drugs. ?�$��|�.E��x/J��=��*�� t5�g5��*GP2�i(�GQo�c^U�y��o��������Cx]@%��B��l���Y�Z9���S�>�G�^��O��ţ:�K$* Additional experience with putative mood stabilizers and atypical agents in mixed mania should include an exploration of their efficacy in treating both manic and depressive mood symptoms. Dysphoric mania, also called agitated or mixed mania, is when you have a combination of depression and mania at the same time. Dysphoric mania is defined as experiencing symptoms of mania and … startxref �`�U� �B��VC�$3�R�ţ��7Z��/K��%��� ��������#�����2�뎮���=}Ӽ�з���:=�!
%%EOF 51 0 obj <> endobj ��:�Naqq �h ������]�2:��dRR266IK�耹*g�c[��s4���m�iQ ���2�1�0�7]c��-�� j�����y�"�s9r�?P��aaX`���#[�p�9����)�����Est|l REY�Ak���R�@| � :�ik This site needs JavaScript to work properly. Among these patients, olanzapine-treated patients had greater improvement within 1 week than did placebo-treated patients on both mania ratings (Y-MRS: -9.7 vs. -3.0 points; = 0.011) and depressive symptom ratings (HAM-D: -9.9 vs. -5.4 points; = 0.025). �*rN�0�x70l܇q��3�37����%\����G�|��Vx�?>���� 3�E���ǔ�kת������ O?9��f#J��e�֩�\��b��UE��E��A�'v5�jZ��=��t��kT5U�Ǟv�����1el�`��L
0000006867 00000 n Among those manic subjects without prominent depressive symptoms (olanzapine, n = 91; placebo, n = 87), mean Y-MRS improvement from baseline to endpoint with olanzapine (-11.5 points) versus placebo (-6.13 points) was comparable to the improvement seen with olanzapine versus placebo in the dysphoric mania subgroup ( = 0.476, test of interaction). 0000002082 00000 n 0000021807 00000 n 0000021206 00000 n
x�b```"7V�� ���,���us�%X옧0�b9�R���Y�8�e2`d1:c��M拠�������.��
The magnitude of the antimanic response appears similar, regardless of baseline depressive features.